L. Kawamura

发表

A Tuberculosis Outbreak in a Private-Home Family Child Care Center in San Francisco, 2002 to 2004

N. Abernethy, P. Dewan, H. Banouvong, 2006, Pediatrics.

Treatment outcomes of patients with HIV and tuberculosis.

B. D. de Jong, P. Hopewell, L. Kawamura, 2007, American journal of respiratory and critical care medicine.

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis

B. D. de Jong, P. Hopewell, L. Kawamura, 2011, BMC infectious diseases.

A Summary of Meeting Proceedings on Addressing Variability around the Cut Point in Serial Interferon-γ Release Assay Testing

S. Dorman, R. Reves, L. Kawamura, 2013, Infection Control & Hospital Epidemiology.

Microevolution of the Direct Repeat Locus of Mycobacterium tuberculosis in a Strain Prevalent in San Francisco

P. Small, N. Abernethy, L. Kawamura, 2006, Journal of Clinical Microbiology.

Predictive value of contact investigation for identifying recent transmission of Mycobacterium tuberculosis.

M. Behr, P. Small, P. Hopewell, 1998, American journal of respiratory and critical care medicine.

Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay

S. Liska, P. Dewan, J. Grinsdale, 2006, BMC infectious diseases.

Improving tuberculosis therapy completion after jail: translation of research to practice.

L. Kawamura, M. White, J. Tulsky, 2004, Health education research.

Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trial.

Jihane, M. Pandori, P. Hopewell, 2014, American journal of respiratory and critical care medicine.

Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.

L. Kawamura, S. Bamrah, R. Brostrom, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein.

E. Engleman, L. Kawamura, N. Mohagheghpour, 1998, Journal of immunology.

Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis.

Raymund B. Dantes, P. Hopewell, J. Grinsdale, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

And The Beat Goes On

L. Kawamura, C. Daley, R. Jasmer, 2005 .

Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy.

Christopher B. Seaman, L. Kawamura, L. C. Gonzalez, 2004, American journal of respiratory and critical care medicine.

Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approach.

P. Hopewell, L. Kawamura, L. C. Gonzalez, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Empirical Evidence for Synchrony in the Evolution of TB Cases and HIV+ Contacts among the San Francisco Homeless

L. Kawamura, M. Mohtashemi, 2010, PloS one.

Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects.

E. Vittinghoff, P. Hopewell, J. Grinsdale, 2010, American journal of respiratory and critical care medicine.

First performance report of QIAreach™ Anti-SARS-CoV-2 Total Test, an innovative nanoparticle fluorescence digital detection platform

L. Kawamura, R. Uchiyama, Sonia N. Rao, 2020, Journal of Clinical Virology.

The role of molecular epidemiology in contact investigations: a US perspective.

L. Kawamura, C. Daley, 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Molecular epidemiology of tuberculosis in foreign-born persons living in San Francisco.

P. Hopewell, J. Grinsdale, L. Kawamura, 2013, American journal of respiratory and critical care medicine.

Tuberculosis in Healthcare Workers: A Molecular Epidemiologic Study in San Francisco

L. Kawamura, J. Creasman, L. C. Gonzalez, 2006, Infection Control & Hospital Epidemiology.

Low Sensitivity of a Whole-Blood Interferon-γ Release Assay for Detection of Active Tuberculosis

P. Dewan, J. Grinsdale, L. Kawamura, 2007 .

Reaching the limits of tuberculosis prevention among foreign-born individuals: a tuberculosis-control program perspective.

P. Hopewell, J. Grinsdale, L. Kawamura, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Interferon-Gamma Release Assays and Pediatric Public Health Tuberculosis Screening: The San Francisco Program Experience 2005 to 2008.

J. Grinsdale, L. Kawamura, J. Higashi, 2016, Journal of the Pediatric Infectious Diseases Society.

The Clinical And Public Health Impact Of Automated Nucleic Acid Testing For TB Evaluation In San Francisco

M. Pandori, P. Hopewell, H. Banouvong, 2011, ATS 2011.

Interferon-γ release assays for prediction of tuberculosis.

J. Grinsdale, L. Kawamura, J. Jereb, 2012, The Lancet. Infectious diseases.

Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis.

P. Dewan, J. Grinsdale, L. Kawamura, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Changes in characteristics of inmates with latent tuberculosis infection.

J. Grinsdale, L. Kawamura, M. White, 2012, Public health.

Isoniazid vs. Rifampin for Latent Tuberculosis Infection in Jail Inmates

J. Spetz, L. Kawamura, M. White, 2012, Journal of correctional health care : the official journal of the National Commission on Correctional Health Care.

Too little too late: Waiting for TB to come

L. Kawamura, L. Masae Kawamura, 2018, Indian Journal of Tuberculosis.

What is Tuberculosis (TB)?

L. Kawamura, M. Campo, 2017, American journal of respiratory and critical care medicine.

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.

P. Hopewell, L. Kawamura, C. Daley, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Multicenter Clinical Trial

E. Vittinghoff, P. Hopewell, L. Kawamura, 2002, Annals of Internal Medicine.

Use of Whole Genome Sequencing to Determine the Microevolution of Mycobacterium tuberculosis during an Outbreak

Nader Pourmand, Midori Kato-Maeda, Laura Flores, 2013, PloS one.

Quantitative impact of human immunodeficiency virus infection on tuberculosis dynamics.

P. Hopewell, L. Kawamura, C. Daley, 2007, American journal of respiratory and critical care medicine.

Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay

L. Kawamura, K. Winthrop, J. Ku, 2018, Journal of Clinical Microbiology.

Incidence of TB in inmates with latent TB infection: 5-year follow-up.

L. Kawamura, M. White, J. Tulsky, 2005, American journal of preventive medicine.

Early Detection of Tuberculosis Outbreaks among the San Francisco Homeless: Trade-Offs Between Spatial Resolution and Temporal Scale

Mojdeh Mohtashemi, J. Grinsdale, L. Kawamura, 2007, PloS one.

The role of molecular epidemiology in contact investigations: a US perspective.

L. Kawamura, C. Daley, 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Beijing Sublineages of Mycobacterium tuberculosis Differ in Pathogenicity in the Guinea Pig

V. Fofanov, P. Hopewell, L. Kawamura, 2012, Clinical and Vaccine Immunology.

What is Tuberculosis (TB)?

L. Kawamura, M. Campo, 2017, American journal of respiratory and critical care medicine.

A 13-year molecular epidemiological analysis of tuberculosis in San Francisco.

P. Hopewell, L. Kawamura, L. C. Gonzalez, 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.